Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3' sulfo-galactosyl ceramide-positive cell line

Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from...

Full description

Saved in:
Bibliographic Details
Published inJournal of Virology Vol. 69; no. 12; pp. 7383 - 7390
Main Authors Harouse, J M, Collman, R G, González-Scarano, F
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 01.12.1995
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JVI .asm.org, visit: JVI       
AbstractList The primary receptor for human immunodeficiency virus (HIV) is the CD4 molecule; however, in vitro evidence suggests that a neutral glycolipid, galactosyl ceramide (GalCer) or a derivative molecule, 3' sulfogalactosyl ceramide (GalS), may serve as an alternative receptor for HIV type 1 (HIV-1) in cells of neural and colonic origin. Biochemical studies have demonstrated that recombinant gp120 envelope protein binds to GalCer/GalS in both solid-phase enzyme-linked immunosorbent assay and high-performance thin-layer chromatography overlays. We have used the SK-N-MC cell line, a CD4-negative, GalCer/GalS-positive cell line previously characterized as susceptible to HIV-1 infection, to identify virus isolates with either a positive infection phenotype, HIVHxB2, or a negative infection phenotype, HIV-1(89.6). Using a solid-phase virus binding assay, we determined the level of restriction in HIV-1(89.6) infection to be at the level of virus-glycolipid binding. Furthermore, using HIV-1HxB2-HIV-1(89.6) chimeras, we have identified a 193-amino-acid fragment from the envelope region of HIV-1HxB2 containing the V3, V4, and V5 regions which confers a positive infection phenotype on the HIV-1(89.6) background. Recombinant viruses which separate this 193-amino-acid fragment into two distinct chimeras are each able to confer a positive infection phenotype on the background of HIV89.6, suggesting that a stable GalCer/GalS-envelope interaction is dependent on the conformation of the envelope protein in the context of the viral membrane. Alternatively, the GalCer/GalS-gp120 bond may involve multiple sites on the oligomeric envelope protein.
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JVI .asm.org, visit: JVI       
The primary receptor for human immunodeficiency virus (HIV) is the CD4 molecule; however, in vitro evidence suggests that a neutral glycolipid, galactosyl ceramide (GalCer) or a derivative molecule, 3' sulfo-galactosyl ceramide (GalS), may serve as an alternative receptor for HIV type 1 (HIV-1) in cells of neural and colonic origin. Biochemical studies have demonstrated that recombinant gp120 envelope protein binds to GalCer/GalS in both solid-phase enzyme-linked immunosorbent assay and high-performance thin-layer chromatography overlays. We have used the SK-N-MC cell line, a CD4-negative, GalCer/GalS-positive cell line previously characterized as susceptible to HIV-1 infection, to identify virus isolates with either a positive infection phenotype, HIV sub(HxB2), or a negative infection phenotype, HIV-1 sub(89.6). Using a solid-phase virus binding assay, we determined the level of restriction in HIV-1 sub(89.6) infection to be at the level of virus-glycolipid binding. Furthermore, using HIV-1 sub(HxB2)-HIV-1 sub(89.6) chimeras, we have identified a 193-amino-acid fragment from the envelope region of HIV-1 sub(HxB2) containing the V3, V4, and V5 regions which confers a positive infection phenotype on the HIV-1 sub(89.6) background. Recombinant viruses which separate this 193-amino-acid fragment into two distinct chimeras are each able to confer a positive infection phenotype on the background of HIV sub(89.6), suggesting that a stable GalCer/GalS-envelope interaction is dependent on the conformation of the envelope protein in the context of the viral membrane. Alternatively, the GalCer/GalS-gp120 bond may involve multiple sites on the oligomeric envelope protein.
Author R G Collman
F González-Scarano
J M Harouse
AuthorAffiliation Department of Neurology, School of Medicine University of Pennsylvania, Philadelphia 19104-6146, USA
AuthorAffiliation_xml – name: Department of Neurology, School of Medicine University of Pennsylvania, Philadelphia 19104-6146, USA
Author_xml – sequence: 1
  givenname: J M
  surname: Harouse
  fullname: Harouse, J M
  organization: Department of Neurology, School of Medicine University of Pennsylvania, Philadelphia 19104-6146, USA
– sequence: 2
  givenname: R G
  surname: Collman
  fullname: Collman, R G
– sequence: 3
  givenname: F
  surname: González-Scarano
  fullname: González-Scarano, F
BackLink https://www.ncbi.nlm.nih.gov/pubmed/7494242$$D View this record in MEDLINE/PubMed
BookMark eNqFkktv1DAUhS1UVKaFn4BksYBNPfUjDxupCzQUWiiw4CF2luNcz7hK7CFOgua38edImFEFCImVr_Sdc32PdE7QUYgBEMKMLhnj8vzNl-tloZaML0shBSmFmoBS-T20YFRJkucsO0ILSjknuZBfH6CTlG4pZVlWZMfouMxUxjO-QD-uhtYE7Nt2CLEG562HYHd49N2QcL_bAmbYBwe29zHg6PDHt-Q9ebfCFpomPcd1bI0PaSbrLeN0Eo-xGaGeBgyh73bT0Eds8OplRgKsTe9HOMNr0xjbx7Rrpk2daX0N5-IZTkPjIvkHJNuY_Gz99TFufICH6L4zTYJHh_cUfX51-Wl1RW4-vL5evbghNudlT3htBWWFUIJJLkXl8pI6EFaZylBRmaw2QlaFBVE7BzVnIjdSuELSmlfUGHGKLvZ7t0PVQm3nVKbR2863ptvpaLz-kwS_0es4aiZVUWaT_-nB38VvA6Retz7NKUyAOCRdloWSStH_ClmhyryQ-SSUe6HtYkoduLtjGNVzQfTt6HWhNON6LoieC6LngkzWx7-HuTMeGjHxJ3u-8evNd9-BNqn9a534CWRRyU0
CitedBy_id crossref_primary_10_1007_BF02174000
crossref_primary_10_1007_BF02174004
crossref_primary_10_1007_BF02258044
crossref_primary_10_1016_S0165_0378_98_00059_X
crossref_primary_10_1097_00126334_200009010_00001
crossref_primary_10_1021_bi961205g
crossref_primary_10_1097_00002030_199804000_00002
crossref_primary_10_1128_JVI_06561_11
crossref_primary_10_1016_j_febslet_2009_11_089
crossref_primary_10_1007_BF02174011
crossref_primary_10_1016_j_ab_2014_08_033
crossref_primary_10_1016_S1367_5931_98_80035_5
crossref_primary_10_1074_jbc_273_14_7967
crossref_primary_10_1007_BF02174014
crossref_primary_10_1039_C6RA06969J
crossref_primary_10_1128_JVI_01303_06
crossref_primary_10_4052_tigg_21_255
crossref_primary_10_1016_j_nano_2015_03_008
crossref_primary_10_3389_fmicb_2015_00749
crossref_primary_10_1016_j_virol_2006_07_029
crossref_primary_10_1097_00002030_199906180_00018
crossref_primary_10_1007_BF02174017
crossref_primary_10_1021_bc034156a
crossref_primary_10_1128_AAC_48_5_1614_1623_2004
crossref_primary_10_1016_j_abb_2007_01_026
crossref_primary_10_1006_viro_1998_9216
crossref_primary_10_1097_00002030_199711000_00004
crossref_primary_10_1002_bit_20680
crossref_primary_10_1093_glycob_cwj122
crossref_primary_10_1038_nm0197_42
crossref_primary_10_1128_JVI_73_1_638_649_1999
crossref_primary_10_1002_mrd_1122
crossref_primary_10_1089_aid_1997_13_1203
crossref_primary_10_1194_jlr_R026682
crossref_primary_10_1097_01_aids_0000206499_78664_58
crossref_primary_10_1016_j_jconrel_2014_04_033
crossref_primary_10_1097_00042560_200009010_00001
crossref_primary_10_1128_JVI_02496_07
crossref_primary_10_1089_oli_1_1996_6_281
crossref_primary_10_1093_jb_mvs080
crossref_primary_10_1074_jbc_M200554200
crossref_primary_10_1016_S0163_7827_97_00011_8
crossref_primary_10_1016_S1386_6532_01_00193_7
crossref_primary_10_1155_2014_823071
crossref_primary_10_3390_molecules18077912
crossref_primary_10_1074_jbc_272_11_7245
crossref_primary_10_1128_JVI_78_12_6567_6584_2004
crossref_primary_10_1016_S0014_5793_02_03860_7
crossref_primary_10_1006_bbrc_1997_7941
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7U9
H94
7X8
5PM
DOI 10.1128/JVI.69.12.7383-7390.1995
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
AIDS and Cancer Research Abstracts
Virology and AIDS Abstracts
MEDLINE - Academic
DatabaseTitleList
CrossRef

AIDS and Cancer Research Abstracts
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1098-5514
EndPage 7390
ExternalDocumentID 10_1128_jvi_69_12_7383_7390_1995
7494242
jvi_69_12_7383
Genre Research Support, U.S. Gov't, P.H.S
Journal Article
Comparative Study
GrantInformation_xml – fundername: NINDS NIH HHS
  grantid: NS-27405
– fundername: NINDS NIH HHS
  grantid: NS31067
– fundername: NINDS NIH HHS
  grantid: NS30606
GroupedDBID ---
-~X
.55
.GJ
0R~
18M
29L
2WC
39C
3O-
4.4
41~
53G
5GY
5RE
5VS
6TJ
85S
AAYJJ
ABPPZ
ACGFO
ACNCT
ADBBV
AENEX
AFFNX
AGVNZ
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
C1A
CGR
CS3
CUY
CVF
D0S
DIK
E3Z
EBS
ECM
EIF
EJD
F20
F5P
FRP
GX1
H13
HYE
HZ~
IH2
KQ8
MVM
N9A
NPM
O9-
OHT
OK1
P2P
RHF
RHI
RNS
RPM
RSF
TR2
UCJ
UPT
VH1
W2D
W8F
WH7
WOQ
X7M
Y6R
YQT
ZGI
ZXP
~02
~KM
AAYXX
CITATION
7U9
H94
7X8
5PM
ID FETCH-LOGICAL-c527t-2dc301639318283bf570fe3c9aba03ba4da38b6ce3dffed2135a83f680d2b0aa3
IEDL.DBID RPM
ISSN 0022-538X
IngestDate Tue Sep 17 21:12:37 EDT 2024
Thu Oct 24 23:46:09 EDT 2024
Fri Oct 25 01:21:32 EDT 2024
Thu Sep 12 16:49:34 EDT 2024
Sat Sep 28 07:32:52 EDT 2024
Wed May 18 15:27:50 EDT 2016
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c527t-2dc301639318283bf570fe3c9aba03ba4da38b6ce3dffed2135a83f680d2b0aa3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://jvi.asm.org/content/jvi/69/12/7383.full.pdf
PMID 7494242
PQID 16975685
PQPubID 23462
PageCount 8
ParticipantIDs pubmed_primary_7494242
pubmedcentral_primary_oai_pubmedcentral_nih_gov_189674
highwire_asm_jvi_69_12_7383
crossref_primary_10_1128_jvi_69_12_7383_7390_1995
proquest_miscellaneous_77698990
proquest_miscellaneous_16975685
PublicationCentury 1900
PublicationDate 1995-12-01
PublicationDateYYYYMMDD 1995-12-01
PublicationDate_xml – month: 12
  year: 1995
  text: 1995-12-01
  day: 01
PublicationDecade 1990
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of Virology
PublicationTitleAlternate J Virol
PublicationYear 1995
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References 8497073 - J Virol. 1993 Jun;67(6):3649-52
1548783 - J Virol. 1992 Apr;66(4):2577-82
7983725 - J Virol. 1995 Jan;69(1):320-5
1282933 - J Neurosci Res. 1992 Dec;33(4):513-8
8096089 - Science. 1993 Mar 19;259(5102):1749-54
8160767 - Am J Pathol. 1994 Apr;144(4):659-66
1367682 - Curr Opin Biotechnol. 1991 Aug;2(4):622-33
2536142 - Nature. 1989 Jan 26;337(6205):368-70
2786088 - J Virol. 1989 Jun;63(6):2527-33
7884870 - J Virol. 1995 Apr;69(4):2233-9
1378511 - J Virol. 1992 Aug;66(8):4848-54
7888115 - AIDS. 1994 Dec;8(12):1669-74
8411372 - J Virol. 1993 Nov;67(11):6707-15
7045870 - Proc Natl Acad Sci U S A. 1982 Apr;79(8):2709-13
2677235 - J Gen Virol. 1989 Oct;70 ( Pt 10):2653-60
1551875 - J Biol Chem. 1992 Apr 5;267(10):6664-71
7909962 - Science. 1994 May 20;264(5162):1161-2; author reply 1162-5
7809077 - Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12559-63
3094962 - Cell. 1986 Nov 7;47(3):333-48
1857969 - Science. 1991 Jul 19;253(5017):320-3
2571666 - J Exp Med. 1989 Oct 1;170(4):1149-63
7687303 - J Virol. 1993 Aug;67(8):4785-96
7903479 - Science. 1993 Dec 24;262(5142):2045-50
2578615 - Nature. 1985 Jan 24-30;313(6000):277-84
6977490 - Immunogenetics. 1982;15(2):199-206
7504741 - J Virol. 1994 Jan;68(1):469-84
8145919 - Neurology. 1994 Mar;44(3 Pt 1):481-7
3472222 - Proc Natl Acad Sci U S A. 1987 May;84(10):3526-30
8184533 - Virology. 1994 Jun;201(2):206-14
1995952 - J Virol. 1991 Mar;65(3):1543-50
7815477 - J Virol. 1995 Feb;69(2):1013-8
1727490 - J Virol. 1992 Jan;66(1):305-9
1404602 - J Virol. 1992 Nov;66(11):6547-54
7853514 - J Virol. 1995 Mar;69(3):1755-61
1920627 - J Virol. 1991 Nov;65(11):6094-100
2293663 - J Virol. 1990 Jan;64(1):215-21
8057468 - J Virol. 1994 Sep;68(9):5890-8
1673040 - Virology. 1991 Apr;181(2):703-15
2172833 - Nature. 1990 Nov 1;348(6296):69-73
7856100 - Virology. 1995 Feb 1;206(2):878-84
2304148 - J Virol. 1990 Mar;64(3):1383-7
1279195 - J Virol. 1992 Dec;66(12):6997-7004
2683359 - Virology. 1989 Nov;173(1):178-87
7831820 - Virology. 1995 Jan 10;206(1):646-50
8424881 - Biotechniques. 1993 Jan;14(1):70-81
2600978 - J Neurosci Res. 1989 Dec;24(4):548-57
2479771 - J Virol. 1989 Dec;63(12):5054-61
8464878 - Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2700-4
1871126 - Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7131-4
2200889 - J Virol. 1990 Sep;64(9):4468-76
1433527 - J Virol. 1992 Dec;66(12):7517-21
2002539 - J Virol. 1991 Apr;65(4):1710-8
1905842 - Science. 1991 Jul 5;253(5015):71-4
References_xml
SSID ssj0014464
Score 1.7736197
Snippet Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
The primary receptor for human immunodeficiency virus (HIV) is the CD4 molecule; however, in vitro evidence suggests that a neutral glycolipid, galactosyl...
SourceID pubmedcentral
proquest
crossref
pubmed
highwire
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 7383
SubjectTerms AIDS/HIV
Antigens, CD - genetics
Antigens, CD - physiology
Base Sequence
Binding Sites
CD4 Antigens - genetics
CD4 Antigens - physiology
Cell Line
Chromatography, High Pressure Liquid
DNA Primers
DNA, Viral - analysis
DNA, Viral - isolation & purification
Enzyme-Linked Immunosorbent Assay
Galactosylceramides - analysis
Galactosylceramides - physiology
HeLa Cells
HIV Envelope Protein gp120 - metabolism
HIV-1 - genetics
HIV-1 - physiology
human immunodeficiency virus
Humans
Kinetics
Molecular Sequence Data
Neuroblastoma
Phenotype
Polymerase Chain Reaction
Receptors, Virus - analysis
Receptors, Virus - physiology
Species Specificity
Sulfoglycosphingolipids
Tumor Cells, Cultured
Title Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3' sulfo-galactosyl ceramide-positive cell line
URI http://jvi.asm.org/content/69/12/7383.abstract
https://www.ncbi.nlm.nih.gov/pubmed/7494242
https://search.proquest.com/docview/16975685
https://search.proquest.com/docview/77698990
https://pubmed.ncbi.nlm.nih.gov/PMC189674
Volume 69
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZNIJBL6St0mz50KPRSrd969Fa2DWlKQqFN2ZuQLClxWdvLenchv61_riPZDt2QXnozjGzLzEj6ZvzNDEJvhYexhbGkUJkmOTeOKOEEoYwxgCMuj01gW1zQ08v8bF7Mh6SwbqBVNqWups2injbVdeBWLusyGnli0bfzWcIFZXm0h_bAPkcPffhzAO5NPlYIh8U8H9k7KY_Ofn6ZUuGjfwz8MsLA3ffJesUhOmC5yNM83T2cxoLB94HPuxzKvw6lk0fo4YAm8cd-1o_RA9s8QQd9f8mbp-h3CNHjyueAtMb6YhE-0xJvq9Wmwz76ihM80rEa3Dr8_Su5IOcz7OP53Qds2lpVTeclV8skjWEwbGdba-ACh54kcLFuscKzTzlp7FUoI_4ew7Hj-_h0Nwt40krVlbFR9g53m4VryT1C0nPHtja8GHvo-wxdnnz-MTslQ7cGUhYpW5PUlLBZAOCBXQIwi3YFi53NSqG0ijOtcqMyrmlpM-OcNWmSFYpnjvLYpDpWKjtC-03b2OcIC_DaGGAzmpQC_E-qlOVOc67L0rmSZxOUjGqSy74ohwzOTMrlr20lqZBJKr2SpVey9EqeoONRn1J19Z1xE_RmVLGE9eW_VTW23XQyoYIVlBf_HsGYb8Ip4gk66k3idk6DVU0Q3bGVW7kv7b0rAYsPJb57C3_xvzceo8OQeh9oNy_R_nq1sa8APK3167Ba_gBMLxqe
link.rule.ids 230,315,730,783,787,888,27936,27937,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZg0Yq9IF4rwgLrAxIX3ObpBzdUWHUfrZDYRb1ZTmwvQW1SNW2l_W38OcZOsqKr5cIt0jiJoxnb30y-mUHovXAwNtOGZCrJScq1JUpYQShjDOCITUPt2RZTOr5Kz2bZrEsKazpaZVXk5aCaLwZV-dNzK5eLYtjzxIbfJqOIC8rS4UP0CJZrmPY-evfvAByctK8RDvJZz9-J-fDsx-mAChf_Y-CZEQYOv0vXyw7QPktFGqfx7vHUlwy-D37eZVH-dSydPEVPOjyJP7fzfoYemOo52m87TN68QL99kB6XLguk1saVi3C5lnhbrjYNdvFXHOGekFXh2uLv52RKJiPsIvrNJ6zrhSqrxkmul1EcwmDY0LZGwwX2XUngYl1jhUdfUlKZa19I_COGg8d18mlu5vCklVqU2gyTD7jZzG1N7hGSlj22Nf7F2IHfl-jq5OvlaEy6fg2kyGK2JrEuYLsAyAP7BKCW3GYstCYphMpVmOQq1SrhOS1Moq01Oo6STPHEUh7qOA-VSg7RXlVX5hXCAvw2BuiMRoUAD5QqZbjNOc-LwtqCJwGKejXJZVuWQ3p3Juby17aUVMgolk7J0ilZOiUH6KjXp1TN4s64AB33Kpawwty3qsrUm0ZGVLCM8uzfIxhzbThFGKDD1iRu59RZVYDojq3cyl1x710J2Lwv8t3a-Ov_vfEYPR5fTi7kxen0_Agd-ER8T8J5g_bWq415C1Bqnb_zK-cPSHId9A
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKUVEviFfVUKA-IHHBm7cf3NCWVR90VQmK9mY5sV2CdpPVZnel_jb-HGNnU7FVuXCLNE7iaMb2N5NvZhB6LxyMzbUhuUoLknFtiRJWEMoYAzhis0h7tsWYnl5n55N8soN4nwvjSftlUQ3q6WxQVz89t3I-K8OeJxZeXQ5jLijLwrm24SP0GJZsRHs_ffP_AJycrK8TDvJJz-FJeHj-42xAhYsBMvDOCAOn36Xs5ftoj2UiS7Jk-4jqywY_BEHvMyn_OppGz9DTDabEn7u5P0c7pn6B9rouk7cv0W8fqMeVywRptHElI1y-JV5Xi1WLXQwWx7gnZdW4sfjbBRmTyyF2Uf32E9bNTFV16yQ38ziJYDBsamuj4QL7ziRwsWywwsOTjNTmxhcT_4jh8HHdfNrbKTxpoWaVNmH6AberqW3IA0LSMcjWxr8YOwD8Cl2PvnwfnpJNzwZS5glbkkSXsGUA7IG9ApBLYXMWWZOWQhUqSguVaZXygpYm1dYancRprnhqKY90UkRKpQdot25qc4iwAN-NAUKjcSnAC6VKGW4LzouytLbkaYDiXk1y3pXmkN6lSbj8ta4kFTJOpFOydEqWTskBOur1KVU7uzcuQMe9iiWsMvetqjbNqpUxFSynPP_3CMZcK04RBeigM4m7OW2sKkB0y1bu5K7A97YE7N4X-u7s_PX_3niMnlydjOTXs_HFEdr3ufieh_MG7S4XK_MW0NSyeOcXzh9Vtx8H
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Human+immunodeficiency+virus+type+1+infection+of+SK-N-MC+cells%3A+domains+of+gp120+involved+in+entry+into+a+CD4-negative%2C+galactosyl+ceramide%2F3%27+sulfo-galactosyl+ceramide-positive+cell+line&rft.jtitle=Journal+of+virology&rft.au=Harouse%2C+J+M&rft.au=Collman%2C+R+G&rft.au=Gonz%C3%A1lez-Scarano%2C+F&rft.date=1995-12-01&rft.issn=0022-538X&rft.volume=69&rft.issue=12&rft.spage=7383&rft.epage=7390&rft_id=info:doi/10.1128%2FJVI.69.12.7383-7390.1995&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon